Health Condition 1: L218- Other seborrheic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients clinically diagnosed with active adherent dandruff of the scalp. 2)Patients having ASFS 6-34.16 3)Patient whose previous treatment for HazÄ?z (pityriasis capitis) ended/stopped before 14 days 4)Willing and able to participate in the trial as an outpatient and comply with all trial requirements.
Exclusion criteria
Exclusion criteria: 1)Pregnant or lactating women. 2)Other inflammatory skin disease in the treatment area that may confound the evaluation of the HazÄ?z (pityriasis capitis) (e.g., atopic dermatitis, tinea capitis and psoriasis) 3)Patients with damaged scalp. 4)Patients with history or presence of any serious disease including immunological conditions like HIV, current malignancies, diabetes mellitus. Hypertension, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: Decrease in Adherent Scalp Flaking Score (ASFS) from baseline to the end of treatment.Timepoint: At baseline, 1st week, 2nd week, 3rd week and 4th week. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease in Dermatology Life Quality Index (DLQI) Decrease in Investigatorsâ?? Global Assessment (IGA) for pruritus.Timepoint: At baseline and 4th week. | — |
Countries
India
Contacts
Luqman Unani Medical College Hospital and Research center